×

1. 골수이식후 나타나는 거대세포 바이러스 감염증의 임상양상

[2007~2009년 대표논문]
1. Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae, Yoon Young Cho, Deok Hwan Yang, Je-Jung Lee, Hyeoung-Joon Kim, Ho Jin Shin, Joo Seop Chung, Goon Jae Cho, Won-Sik Lee, Young-Don Joo,
Chang-Hak Sohn, Suk Joong Oh
Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study
Cancer Chemother Pharmacol (2007) 60(1):129-34

2. Dong Il Park, Mun Su Kang, Suk Joong Oh, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon , Byung Ik Kim, Won Kon Han, Hungdai Kim, Seung Ho Ryu, Antonia R. Sepulveda
HER-2/neu overexpression is an independent prognostic factor in colorectal cancer
Int J Colorectal Dis (2007) 22(5):491-7

3. Byeong-Bae Park, Won Seog Kim, Hyeon Seok Eom, Jin Seok Kim, Young Yiul Lee, Suk Joong Oh, Dae Ho Lee, Cheolwon Suh
Salvage therapy with gemcitabine, ifosfamide, examethasone,and oxaliplatin (GIDOX) for B-cell non-Hodgkin’’s lymphoma: a consortium for improving survival of lymphoma (CISL) trial
Invest New Drugs 2009 (Epub ahead of print)

4. Byeong-Bae Park, Jong Gwang Kim, Sang Kyun Sohn, Hye Jin Kang, Seung Sook Lee, Hyeon Seok Eom, Hyuck Chan Kwon, Sung Yong Oh, Jung Hun Kang, Suk Joong Oh, Ho-Jin Shin, Cheolwon Suh, Jung Han Kim, Ho Young Kim, Kihyun Kim, Baek Yeol Ryoo, and Won Seog Kim
Consideration of aggressive therapeutic strategies for primary testicular lymphoma
American Journal of Hematology 2007;82(9):840-5

5. Min Jae Park, Jeeyun Lee, Jung Yong Hong, Moon Ki Choi, Joon Ho Yi, Su Jin Lee, Suk Joong Oh, Jin Seok Ahn, Keunchil Park, and Myung Ju Ahn
Prognostic Model to Predict Outcomes in Nonsmall Cell Lung Cancer Patients Treated With Gefitinib as a
Salvage Treatment
Cancer. 2009;115(7):1518-30

6. Hyeon-Seok Eom, Yeo-Kyeoung Kim, Joo-Seop Chung, Kihyun Kim, Hyo Jung Kim, Ho Young Kim, Jong-Youl Jin, Young-Rok Do, Suk-Joong Oh, Cheolwon Suh, Chu-Myong Seong, Chul Soo Kim, Dong Soon Lee, Jae Hoon Lee
Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)
Ann Hematol. 2009;89(5):489-97

7. SJ Oh, SB Cho, S-H Park, CZ Piao, SM Kwon, I Kim, SS Yoon, BK Kim, EK Park ,JJ Kang, S-J Yang, WJ Lee, C-H Yoo, S Hwang, SH Kim, JH Kim, and S Park
Cell cycle and immune-related processes are significantly altered in chronic GVHD
Bone Marrow Transplantation (2008)41(12):1047-57

8. Sung Yong Oh, Baek-Yeol Ryoo, Won Seog Kim, Yeon Hee Park, Kihyun Kim, Hyun Jung Kim, Jung Mi Kwon, Jeeyun Lee, Young Hye Ko, Yong Chan Ahn, Suk Joong Oh, Soon Il Lee, Hyo-Jin Kim, Hyuk-Chan Kwon, Soo Mee Bang, Jung Han Kim, Jinny Park, Seung-Sook Lee, Ho Young Kim, and Keunchil Park
Nongastric Marginal Zone B-Cell Lymphoma: Analysis of 247 Cases
American Journal of Hematology (2007) 258(1):90-7

9. Yuna Lee, Ji Eun Uhm, Hui-Young Lee, Min Jae Park, Hyeongsu Kim, Suk Joong Oh, Jun Ho Jang, Kihyun Kim, Chul Won Jung, Yong Chan Ahn, Keunchil Park, Young Hyeh Ko, Won Seog Kim
Clinical features and prognostic factors of patients with ““peripheral T cell lymphoma, unspecified””
Ann Hematol (2009) 88(2):111-9